Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FRA:E9Q's PS Ratio is ranked better than 88.62% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.45
vs FRA:E9Q: 0.28
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Guangdong Kanghua Healthcare Group Co PS Ratio Related Terms
Guangdong Kanghua Healthcare Group Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangdong Kanghua Healthcare Group Co PS Ratio Chart
For the Medical Care Facilities subindustry, Guangdong Kanghua Healthcare Group Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Kanghua Healthcare Group Co PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Guangdong Kanghua Healthcare Group Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Guangdong Kanghua Healthcare Group Co's PS Ratio falls into.
Guangdong Kanghua Healthcare Group Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Guangdong Kanghua Healthcare Group Co's Share Price of today is €0.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Guangdong Kanghua Healthcare Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €0.73.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a PS Ratio of 0.27 as of Jul. 26, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. This is 37% below median its historical median of 0.43. Over the past decade, Guangdong Kanghua Healthcare Group Co's PS Ratio has ranged from 0.19 to 2.81. According to the industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #75 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 11.4%.
Is Guangdong Kanghua Healthcare Group Co's PS Ratio too high?
Guangdong Kanghua Healthcare Group Co's current PS Ratio of 0.27 is 37% below median its 10-year median of 0.43. Over the past 10 years, this metric has ranged from a low of 0.19 to a high of 2.81. The Healthcare Providers & Services industry median PS Ratio is 1.45. Guangdong Kanghua Healthcare Group Co's value of 0.27 is 81.4% below this industry median. Based on the distribution chart, Guangdong Kanghua Healthcare Group Co ranks #75 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Guangdong Kanghua Healthcare Group Co has a GF Score™ of 82/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Kanghua Healthcare Group Co's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Guangdong Kanghua Healthcare Group Co ranks #75 out of 659 companies for PS Ratio. This places Guangdong Kanghua Healthcare Group Co in the top 11% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.45. Guangdong Kanghua Healthcare Group Co's value of 0.27 is 81.4% below this benchmark. Historically, Guangdong Kanghua Healthcare Group Co's own PS Ratio has ranged from 0.19 to 2.81 over the past decade. While the company's 10-year median is 0.43 vs. the industry median of 1.45, Guangdong Kanghua Healthcare Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.45, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Kanghua Healthcare Group Co's current PS Ratio of 0.27 is 81.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Guangdong Kanghua Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Kanghua Healthcare Group Co's current PS Ratio is 0.27, which is 37% below median its own 10-year median of 0.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Kanghua Healthcare Group Co stock overvalued right now?
Guangdong Kanghua Healthcare Group Co (FRA:E9Q) has a current PS Ratio of 0.27. The stock's GF Value™ is €0.22, compared to a current price of €0.20 — trading 9.1% below its estimated fair value. The current PS Ratio is 0.27, which is 37% below median its 10-year median of 0.43 and 81.4% below the Healthcare Providers & Services industry median of 1.45. Guangdong Kanghua Healthcare Group Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Guangdong Kanghua Healthcare Group Co (FRA:E9Q), the current PS Ratio is 0.27 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangdong Kanghua Healthcare Group Co (FRA:E9Q) Overvalued in 2026?
Based on GuruFocus' analysis, Guangdong Kanghua Healthcare Group Co stock appears to be undervalued.
The current stock price of €0.20 is trading 9.1% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:E9Q:
PS Ratio: 0.27 (37% below median its 10-year median of 0.43)
GF Value™: €0.22 vs. price of €0.20 (9.1% below fair value)
Industry Position: 81.4% below the Healthcare Providers & Services median (#75 of 659)
No single metric tells the full story. See the FRA:E9Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangdong Kanghua Healthcare Group Co Business Description
Guangdong Kanghua Healthcare Group Co Ltd provides healthcare services. The reportable segments are as follows, The Hospital services segment, which generates majority revenue, includes the provision of hospital services including inpatient healthcare services, outpatient healthcare services, and physical examination services; Rehabilitation and other healthcare services including the provision of rehabilitation services; Elderly healthcare services include the provision of elderly healthcare services, including assisted living, adult daycare, longterm care, residential care and hospice care to the aged patients; and Haemodialysis services segment is principally engaged in the operation of haemodialysis outpatient centres. It generates all of its revenue from the PRC.
82GF Score
Get the complete analysis for FRA:E9Q
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:E9Q has been successfully added to your 
